Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine (EFFORT)
Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine - a Randomized Controlled Trial in P. Vivax Patients
Sponsor: Aga Khan University
This PHASE3 trial investigates Malaria Relapse and Malaria, Vivax and is currently completed. Aga Khan University leads this study, which shows 13 recorded versions since 2021 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
13 versions recorded-
Nov 2024 — Present [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
Jul 2023 — Apr 2024 [monthly]
Recruiting PHASE3
▶ Show 8 earlier versions
-
Jun 2023 — Jul 2023 [monthly]
Recruiting PHASE3
-
Sep 2022 — Jun 2023 [monthly]
Recruiting PHASE3
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE3
-
May 2022 — Jun 2022 [monthly]
Recruiting PHASE3
-
Sep 2021 — May 2022 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aga Khan University
- Arba Minch University
- Ethiopian Public Health Institute
- Mahidol Oxford Tropical Medicine Research Unit
- Menzies School of Health Research
- National Centre for Parasitology, Entomology and Malaria Control, Cambodia
- Universitas Sumatera Utara
- University of Melbourne
For direct contact, visit the study record on ClinicalTrials.gov .